Nealbarbital
From Wikipedia, the free encyclopedia
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
5-allyl-5-(1,1-dimethylpropyl)pyrimidine-2,4,6(1H,3H,5H)-trione
|
|
| Identifiers | |
| CAS Number | 561-83-1  |
| ATC code | none |
| PubChem | CID 521716 |
| ChemSpider | 455089 |
| UNII | 25ATP958PA |
| Synonyms | Nealbarbital, Censedal |
| Chemical data | |
| Formula | C12H18N2O3 |
| Molar mass | 238.28 g/mol |
| 3D model (Jmol) | Interactive image |
|
|
|
|
| (verify) | |
Nealbarbital (Censedal) is a barbiturate derivative developed by Aktiebolaget Pharmacia in the 1950s.[1] It has sedative and hypnotic effects, and was used for the treatment of insomnia.
References[edit]
- ^ US Patent 2899435
 |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
